Absci (ABSI) Amortizatization of Intangibles (2022 - 2026)
Absci (ABSI) reported Amortizatization of Intangibles of $421000.0 for Q1 2026, down 39.77% on a YoY basis from $699000.0 in Q1 2025, and down 20.11% sequentially from $527000.0 in Q4 2025.
Absci (ABSI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Absci (ABSI) has 5 years of Amortizatization of Intangibles data on file, last reported at $421000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 39.77% year-over-year to $421000.0; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 40.57% YoY), and the FY2025 full-year result was $2.5 million, down 32.06% from the prior year.
- Amortizatization of Intangibles retreated to $421000.0 in Q1 2026, from $527000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q2 2024 to a low of $396000.0 in Q4 2023.
- A 5-year average of $719000.0 and a median of $678500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles surged 97.47% in 2024 and plunged 44.8% in 2025, its largest moves.
- Tracing ABSI's Amortizatization of Intangibles over 5 years: stood at $688000.0 in 2022, then sank by 42.44% to $396000.0 in 2023, then surged by 97.47% to $782000.0 in 2024, then sank by 32.61% to $527000.0 in 2025, then retreated by 20.11% to $421000.0 in 2026.
- Business Quant data shows ABSI's Amortizatization of Intangibles at $421000.0 in Q1 2026, $527000.0 in Q4 2025, and $648000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Absci | 1.17 Bn | 1.05 Bn | - | 421,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 421,000.00 |
| Mar 31, 2026 | 421,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Sep 30, 2025 | 648,000.00 |
| Sep 30, 2025 | 648,000.00 |
| Jun 30, 2025 | 669,000.00 |
| Jun 30, 2025 | 669,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 782,000.00 |
| Dec 31, 2024 | 782,000.00 |
| Sep 30, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 631,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Dec 31, 2023 | 396,000.00 |